Compare ARQT & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | AVAH |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 1.9B |
| IPO Year | 2020 | 2021 |
| Metric | ARQT | AVAH |
|---|---|---|
| Price | $29.68 | $8.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $24.83 | $10.19 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 02-24-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.37 |
| Revenue | $317,929,000.00 | ★ $2,290,591,000.00 |
| Revenue This Year | $85.51 | $20.08 |
| Revenue Next Year | $30.74 | $7.12 |
| P/E Ratio | ★ N/A | $24.14 |
| Revenue Growth | ★ 129.21 | 15.48 |
| 52 Week Low | $11.13 | $3.67 |
| 52 Week High | $31.77 | $10.32 |
| Indicator | ARQT | AVAH |
|---|---|---|
| Relative Strength Index (RSI) | 55.12 | 52.55 |
| Support Level | $27.71 | $7.68 |
| Resistance Level | $30.26 | $9.27 |
| Average True Range (ATR) | 1.17 | 0.32 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 66.45 | 71.38 |
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.